On January 8, 2024, Akebia Therapeutics (NASDAQ: AKBA) announced the appointment of Richard C. Malabre as Chief Accounting Officer and principal
See Original Article
Gotham City accounting queries wipe $3.83 billion off Grifols value. Reuters. Published Jan 09, 2024 08:00AM ET. Be the first to comment. Gotham
See Original Article
… Gotham City Research questioned its accounting, prompting the Spanish drugmaker to “categorically” deny any wrongdoing.
See Original Article
… accounting officer was stepping down effective January 5, 2024 to pursue another opportunity. Lubi Kutua, the Company's current Chief Financial
See Original Article
Dada said its audit committee will hire independent professional advisers, including forensic accountants and lawyers, to conduct a review.
See Original Article